The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary endpoint results of the phase 3b ASC4START trial of asciminib (ASC) vs nilotinib (NIL) in newly diagnosed chronic phase chronic myeloid leukemia (CML-CP): Time to treatment discontinuation due to adverse events (TTDAE).
 
Andreas Hochhaus
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
François-Xavier Mahon
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Tim Brümmendorf
Honoraria - AstraZeneca; Incyte; Janssen; Merck; Novartis; Pfizer; Roche; SCOR; SYNLAB
Consulting or Advisory Role - Gilead Sciences; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Novartis
(OPTIONAL) Uncompensated Relationships - Repeat DX
 
Phillipp Le Coutre
Honoraria - AOE; BluePrint Health; Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
David Andorsky
Consulting or Advisory Role - Abbvie; Celgene
Research Funding - Abbvie; AstraZeneca; Celgene; Novartis
 
Susanne Saussele
Honoraria - Incyte; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Incyte; Novartis
 
Stephen Strickland
Consulting or Advisory Role - Abbvie (Inst); Kura Oncology (Inst); Novartis (Inst); Senti Biosciences (Inst); SOBI (Inst); Sumitomo Pharma Oncology (Inst); Terns Pharmaceuticals (Inst)
Speakers' Bureau - GlaxoSmithKline (Inst)
Research Funding - Beam Therapeutics (Inst); BlossomHill Therapeutics (Inst); Caribou Biosciences (Inst); Cellectis (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Kumquat Biosciences (Inst); Kura Oncology (Inst); Novartis (Inst); Oryzon Genomics (Inst); Schrodinger (Inst); Senti Biosciences (Inst); Stemline Therapeutics (Inst); Sumitomo Pharma Oncology (Inst); Syros Pharmaceuticals (Inst); SystImmune (Inst); Takeda (Inst); Terns Pharmaceuticals (Inst); Vincerx Pharma (Inst); Vironexis (Inst); Zentalis (Inst)
 
Thomas Cluzeau
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bristol-Myers Squibb/Celgene; Incyte; Jazz Pharmaceuticals; Novartis/Ipsen; Servier/Pfizer
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; Incyte; Novartis; SERVIER; Takeda
Travel, Accommodations, Expenses - Abbvie; Novartis; Pfizer; Roche; SERVIER
 
Françoise Huguet
Consulting or Advisory Role - Amgen; Clinigen Group; Incyte; novartis; Pfizer; SERVIER
Travel, Accommodations, Expenses - Novartis
 
Jirí Mayer
Research Funding - BeiGene; Protagonist Therapeutics; Roche
 
Viviane Dubruille
Honoraria - Novartis
Consulting or Advisory Role - Abbvie; Novartis; Pfizer
Research Funding - Abbvie; Novartis
 
Dong-Wook Kim
Honoraria - Bristol-Myers Squibb; Enliven Therapeutics; IL-Yang Pharm; Korea Otsuka; Novartis
Speakers' Bureau - Bristol-Myers Squibb; IL-Yang Pharm; Korea Otsuka; Novartis
Research Funding - Bristol-Myers Squibb; Enliven Therapeutics; IL-Yang Pharm; Korean Otsuka; Novartis; Pharmaessencia
 
Ilina Micheva
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis
 
Gabrielle Roth Guepin
No Relationships to Disclose
 
Virginia Pilipovic
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jacqueline Ryan
Employment - Novartis Pharmaceutical UK Ltd
Stock and Other Ownership Interests - Novartis
 
Nabil Amirouchene Angelozzi
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Nithya Agrawal
Employment - Novartis
 
Ennan Gu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Delphine Réa
Honoraria - Incyte; Novartis; Pfizer
Consulting or Advisory Role - Incyte; Novartis; Pfizer